The purpose of this study was to demonstrate the feasibility of sensing changes in a tumor during boron neutron capture therapy (BNCT) using a Monte Carlo simulation tool. In the simulation, an epi-thermal neutron source and a water phantom including boron uptake regions (BURs) were simulated. Moreover, this simulation also included a detector for positron emission tomography (PET) scanning and an adaptively-designed collimator (ADC) for PET. After the PET scanning of the water phantom, including the 511 keV source in the BUR, the ADC was positioned in the PET's gantry. Single prompt gamma rays were collected through the ADC during neutron irradiation. Then, single prompt gamma ray-based tomography images of different sized tumors were acquired by a four-step process. Both the signal-to-noise ratio (SNR) and tumor size were analyzed from each step image. From this analysis, we identified a decreasing trend of both the SNR and signal intensity as the tumor size decreased, which was confirmed in all images. In conclusion, we confirmed the feasibility of sensing changes in a tumor during BNCT using PET and an ADC through Monte Carlo simulation.

Purpose:We evaluated the relationship between white matter (WM) tract disintegration and gray matter (GM) atrophy in patients with Alzheimer's disease (AD), mild cognitive impairment (MCI) and controls, using diffusion tensor imaging (DTI) and an optimized voxel‐based analysisMethods:Voxel‐based WM tract statistics was used to obtain whole‐brain maps of WM bundles for FA. Voxel‐based morphometry (VBM) was conducted to detect regions of gray matter (GM) atrophy in the AD, MCI group relative to the control group. FA maps were processed to make voxel‐wise comparison of tract based analysis in whole brain between each the two groups. The relationship between locations of abnormalities in the WM and GM were examined.Results:Patients with AD showed significant GM atrophy in posterior cingulate gyrus (BA31, 32) to the precuneus, the middle temporal lobe (BA19), the superior frontal (BA9) to the anterior cingulate (BA 32), the medial frontal lobe (BA 11, BA25), the hippocampus, the parahippocampal gyrus (BA30/34) and the insula, and WM tract disintegrity of the uncinate fasciculus, posterior cingulate fasciculus and fornix compared with the control and MCI groups. These abnormalities in the AD group were caused by either structural changes in GM atrophy or neural dysfunction due to functional disconnections in the WM tract.Conclusion:The GM atrophy resulting from WM tract disintegration or GM atrophy itself may be the first step in the AD process, resulting in anatomically congruent correlations between WM disintegration and regional GM atrophy. Using tract based spatial statistics and voxel based analysis, both of which are useful in investigating GM and WM changes in individuals with neurodegenerative disorders.

ABSTRACT The purpose of the present study was to develop a hybrid magnetic resonance/computed tomography (MR/CT)-compatible phantom and tissue-equivalent materials for each MR and CT image. Therefore, the essential requirements necessary for the development of a hybrid MR/CT-compatible phantom were determined and the development process is described. A total of 12 different tissue-equivalent materials for each MR and CT image were developed from chemical components. The uniformity of each sample was calculated. The developed phantom was designed to use 14 plugs that contained various tissue-equivalent materials. Measurement using the developed phantom was performed using a 3.0-T scanner with 32 channels and a Somatom Sensation 64. The maximum percentage difference of the signal intensity (SI) value on MR images after adding K2CO3 was 3.31%. Additionally, the uniformity of each tissue was evaluated by calculating the percent image uniformity (%PIU) of the MR image, which was 82.18 ±1.87% with 83% acceptance, and the average circular-shaped regions of interest (ROIs) on CT images for all samples were within ±5 Hounsfield units (HU). Also, dosimetric evaluation was performed. The percentage differences of each tissue-equivalent sample for average dose ranged from −0.76 to 0.21%. A hybrid MR/CT-compatible phantom for MR and CT was investigated as the first trial in this field of radiation oncology and medical physics.

Background: The purpose of this study was to evaluate the feasibility of a multi-purpose quality assurance (QA) phantom for pretreatment verification of volumetric modulated arc therapy (VMAT). Materials and Methods: The QA phantom was constructed with polymethyl methacrylate (PMMA) to perform relative dosimetry using EBT3 film and MapCHECK, as well as absolute dosimetry using an ionization chamber. The QA phantom was constructed to perform relative dosimetry using EBT3 film and MapCHECK, as well as the absolute dosimetry using ionization chamber. In order to verify the pretreatment plans, 25 patients treated with VMAT were selected. The pretreatment plans were calculated in the Eclipse treatment planning system using the Acuros XB dose calculation algorithm and CT images for the QA phantom, with the same beam setup and monitor units (MUs) as those for patient treatment. All plans were delivered to the Varian TrueBeam accelerator equipped with a high-definition multi-leaf collimator. Results: The multi-purpose QA phantom is developed for convenient VMAT dose verification. By using the QA phantom, all 25 cases passed +/- 3% acceptability criteria in absolute dosimetry with an ionization chamber for pretreatment verification. The relative dosimetry using EBT3 film and MapCHECK system also showed high agreement of more than 90% for 2%/2-mm and 3%/3-mm criteria. Conclusion The results of this study demonstrated the good multi-purpose capabilities of the phantom for the absolute and relative dosimetry. Therefore, the developed multi-purpose QA phantom was applied in our institution for routine VMRT dose verification.